microarrays
Through a US-based subsidiary, the South Korean firm has received breakthrough device designation for its bladder cancer test that could accelerate it to market.
Quotient, Theradiag Announce Dx Partnership
Quotient said that it intends to develop a microarray-based test for connective tissue diseases with Theradiag.
Schott Minifab Acquires Applied Microarrays to Expand US Manufacturing Capabilities
The acquisition will expand Schott's biosensor printing capabilities, helping it further manufacture point-of-care microarray consumables.
PathogenDx Gets CE Mark for Microarray-Based COVID-19 Test
The test has also received Emergency Use Authorization from the US Food and Drug Administration and detects SARS-CoV-2 within three hours of RNA extraction.
The firm said it is also eyeing other testing markets for a platform that does immunohematology, serology, and molecular testing.
Jul 11, 2019
Apr 23, 2019
Prescient Medicine Acquires AutoGenomics
May 10, 2018
Arrayit Receives CLIA Certification for Clinical Lab
Apr 19, 2018
Mobidiag Gets CE Marks for Two Tests
Jan 25, 2018